Table 2 Individual parameter values measured in the selected single metastatic ALN (mALN) for each of the BC patient presented in Table 1 and described in Methods and Fig. 4
Parameter | Patients’ number | |||||
|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | |
Diameter of tumor depositsa (mm) | 80.0b | 9.5 | 14.5 | 13.5 | 1.8 | n.a.d |
% of malignant cells | 80% | 100% | 100% | 100% | 30% | n.a. |
Presence of micrometastasisc | none | none | none | none | positive | n.a. |
Initial tissue weight (mg) | 790 | 720 | 190 | 660 | 630 | 530 |
Total viable cell number (× 10− 6) | 18.6 | 3.6 | 5.2 | 9.0 | 3.8 | 3.9 |
Nuclear protein yield (mg) | 3.2 | 0.6 | 1.0 | 1.7 | 1.1 | 0.8 |
Cytosolic protein yield (mg) | 6.5 | 1.2 | 1.7 | 2.5 | 0.9 | 1.2 |
cFOS level (%) | 15.50 | 8.75 | 13.20 | 0.00 | 0.00 | 0.00 |
TGFβ1 level (ng/mg protein) | 3.60 | 1.20 | 0.90 | 1.02 | 0.67 | 1.08 |